(September 2023) Tirzepatide-Induced Gastrointestinal Manifestations: A Systematic Review and Meta-Analysis (September 2023) As Semaglutides Popularity Soars, Rare but Serious Adverse Effects Are Emerging (November 2023) Glucagonlike Peptide-1 Receptor Agonists: The Good, the Bad, and the UglyBenefits for Glucose Control and Weight Loss with Side Effects of Delaying Gastric Emptying (January 2024) Diabetic gastroparesis: a disease for which long-term therapeutic benefits are difficult to obtain (May 2024) Other Possible Side Effects of Zepbound Explored Tirzepatide, the active ingredient in Zepbound, belongs to a class of drugs called GLP-1 agonists
Am J Hypertens
Crajoinas RO, Oricchio FT, Pessoa TD, Pacheco BP, Lessa LM, Malnic G, et al
Creating environmental triggers Leave the oral syringe on the bathroom counter as a visual reminder
That sounds extraordinary
Georgina Glenn July 24th 2026 Georgina Glenn May 19th 2026 Georgina Glenn April 30th 2026